The first age reversal gene therapy ever given to people just reported results. Life Biosciences’ ER-100, co-founded by Harvard’s David Sinclair, uses three Yamanaka factors (OSK) to try to reset aging cells in the eye. In the first three glaucoma patients, the low dose was well tolerated and two of the three improved on visual field testing. We break down how it works, where the viral \.